Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation (Q28196625)

Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study

Europe PubMed Central

title

Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation (English)

0 references

0 references

1 reference

myocardial infarction

1 reference

2

Greg L Plosker

0 references

author name string

David Murdoch

series ordinal

1

0 references

language of work or name

English

0 references

publication date

2006

0 references

published in

Drugs

0 references

volume

66

0 references

issue

5

0 references

page(s)

671-92

0 references

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200666050-00009

A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200666050-00009

Five years of angiographic and clinical follow-up after successful percutaneous transluminal coronary angioplasty

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200666050-00009

Effect of triflusal and other salicylic acid derivatives on cyclic AMP levels in rat platelets

21 January 2018

1 reference

12 December 2020

European Stroke Initiative Recommendations for Stroke Management – Update 2003

1 reference

12 December 2020

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

1 reference

12 December 2020

Can aspirin ever be surpassed for stroke prevention?

1 reference

12 December 2020

Protective effect of triflusal against acute myocardial infarction in patients with unstable angina: results of a Spanish multicenter trial. Grupo de Estudio del Triflusal en la Angina Inestable

1 reference

12 December 2020

Interaction between a rat model of cerebral ischemia and beta-amyloid toxicity: inflammatory responses.

1 reference

12 December 2020

Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteers

1 reference

12 December 2020

High risk of thromboemboli early after bioprosthetic cardiac valve replacement

1 reference

12 December 2020

1 reference

12 December 2020

Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

1 reference

12 December 2020

Comparison of in vitro effects of triflusal and acetysalicylic acid on nitric oxide synthesis by human neutrophils

1 reference

12 December 2020

Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome

1 reference

12 December 2020

Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase

1 reference

12 December 2020

Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial

1 reference

12 December 2020

Effects of triflusal and acetylsalicylic acid on platelet aggregation in whole blood of diabetic patients

1 reference

12 December 2020

Antiplatelet Agents and Their Effect on Complications during or Soon after Percutaneous Transluminal Coronary Angioplasty

1 reference

12 December 2020

Influence of triflusal on platelet activation after coronary artery bypass graft

1 reference

12 December 2020

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

12 December 2020

Pharmacokinetic Study of Triflusal in Elderly Subjects After Single and Repeated Oral Administration

1 reference

12 December 2020

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice g

1 reference

12 December 2020

Randomized comparative trial of triflusal and aspirin following acute myocardial infarction

1 reference

12 December 2020

Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid

1 reference

12 December 2020

Upper gastrointestinal bleeding associated with antiplatelet drugs

1 reference

12 December 2020

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study

1 reference

12 December 2020

A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function

1 reference

12 December 2020

Triflusal : A Viewpoint by F. Pérez Gómez

1 reference

12 December 2020

Comparison of the inhibitory effects of acetylsalicylic acid and trifusal on enzymes related to thrombosis

1 reference

12 December 2020

Pharmacokinetics of triflusal after single and repeated doses in man

1 reference

12 December 2020

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

1 reference

12 December 2020

May aspirin be replaced in the treatment of myocardial infarction?

1 reference

12 December 2020

Guidelines for stroke prevention in patients with atrial fibrillation

1 reference

12 December 2020

Economic evaluation of triflusal and aspirin in the treatment of acute myocardial infarction

1 reference

12 December 2020

Oral administration of the anti-inflammatory substance triflusal results in the downregulation of constitutive transcription factor NF-kappaB in the postnatal rat brain

1 reference

12 December 2020

Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Effect of 4-trifluoromethyl derivatives of salicylate on nuclear factor kappaB-dependent transcription in human astrocytoma cells

1 reference

12 December 2020

Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose

1 reference

12 December 2020

Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke

1 reference

12 December 2020

Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus

1 reference

12 December 2020

4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation

1 reference

12 December 2020

Antithrombotic and thrombolytic therapy for ischemic stroke

1 reference

12 December 2020

Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial

1 reference

12 December 2020

Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers.

1 reference

12 December 2020

Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study

1 reference

12 December 2020

[Comparative study of the effect of low-dosage acetylsalicylic acid and triflusal in the prevention of cardiovascular events among young adults with ischemic cerebrovascular disease]

1 reference

12 December 2020

Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study

1 reference

12 December 2020

Triflusal for preventing serious vascular events in people at high risk

1 reference

12 December 2020

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

1 reference

12 December 2020

Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis

1 reference

12 December 2020

Triflusal posttreatment inhibits glial nuclear factor-kappaB, downregulates the glial response, and is neuroprotective in an excitotoxic injury model in postnatal brain.

1 reference

12 December 2020

Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids

1 reference

12 December 2020

Triflusal : A Viewpoint by José P. De La Cruz

1 reference

12 December 2020

Effects of triflusal on oxidative stress, prostaglandin production and nitric oxide pathway in a model of anoxia-reoxygenation in rat brain slices

1 reference

12 December 2020

Management of acute myocardial infarction in patients presenting with ST-segment elevation

1 reference

12 December 2020

Effects of triflusal on arteriosclerosis progression assessed with high-resolution arterial ultrasound

1 reference

12 December 2020

Interaction between a rat model of cerebral ischemia and beta-amyloid toxicity: II. Effects of triflusal

1 reference

12 December 2020

Platelet antiaggregatory effect of triflusal in human whole blood

1 reference

12 December 2020

Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020